GlassScriptPhysician profile
Veronica D'Andria
NPI 1972127447
$1,765.80
in general payments reported to CMS, 2019-2025
19 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $328 · 2022: $520 · 2023: $371 · 2024: $391 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $319.16 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $278.78 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $197.77 | 2021-2023 | |
| Boston Scientific Corporation | $185.53 | 2022-2024 | Ingevity Mri |
| Janssen Pharmaceuticals, INC | $140.62 | 2021-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $122.10 | 2024 | Uptravi, Opsumit |
| Pfizer INC. | $112.49 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.93 | 2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $44.58 | 2022 | |
| Edwards Lifesciences Corporation | $43.81 | 2023 | |
| Medtronic, INC. | $42.72 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.32 | 2022-2023 | Camzyos |
| Cvrx, INC. | $27.45 | 2024-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.72 | 2022 | |
| Amarin Pharma, INC. | $22.63 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.30 | 2021 | |
| Novo Nordisk INC | $16.19 | 2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $14.50 | 2021 | |
| Merck Sharp & Dohme LLC | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica D'Andria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.